TET2 and Myelodysplasia: These preleukemic HSCs harbor mutations associated with myelodysplasia (e.g., of DNMT3A, TET2, and others), which persist in myeloid cells as well as B and T cells but lack the mutations present in leukemic blasts (57–60).